These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20353368)

  • 81. Reply to "Debilitating fatigue as a treatment indication in chronic hepatitis C".
    Gerber L; Younossi Z
    J Hepatol; 2015 Dec; 63(6):1534-5. PubMed ID: 26375244
    [No Abstract]   [Full Text] [Related]  

  • 82. Reply to "Debilitating fatigue as a treatment indication in chronic hepatitis C".
    Pawlotsky JM; Aghemo A; Back D; Dusheiko G; Forns X; Puoti M; Sarrazin C;
    J Hepatol; 2015 Dec; 63(6):1535-6. PubMed ID: 26375242
    [No Abstract]   [Full Text] [Related]  

  • 83. Re: RP Myers, H Shah, KW Burak, et al. An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol Hepatol 2015;29(1):19-34.
    Myers RP; Shaw H; Burak KW
    Can J Gastroenterol Hepatol; 2015 Mar; 29(2):68. PubMed ID: 25803014
    [No Abstract]   [Full Text] [Related]  

  • 84. Management of Hepatitis C in 2019.
    Marks K; Naggie S
    JAMA; 2019 Jul; 322(4):355-356. PubMed ID: 31099822
    [No Abstract]   [Full Text] [Related]  

  • 85. Equal 3-Year Outcomes for Kidney Transplantation Alone in HCV-Positive Patients With Cirrhosis.
    Parsikia A; Campos S; Khanmoradi K; Pang J; Balasubramanian M; Zaki R; Ortiz J
    Int Surg; 2015 Jan; 100(1):142-54. PubMed ID: 25594655
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Current clinical care compared with new Dutch guidelines for hepatitis C treatment.
    Slavenburg S; Lamers MH; Roomer R; de Knegt RJ; van Oijen MG; Drenth JP
    Neth J Med; 2009 May; 67(5):177-81. PubMed ID: 19581667
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Approach of primary care physicians to hepatitis C: an educational survey from a Southern Italian area.
    Cozzolongo R; Cuppone R; Petruzzi J; Stroffolini T; Manghisi OG
    J Infect; 2005 Dec; 51(5):396-400. PubMed ID: 16321651
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hepatitis C identification and management by family physicians.
    Clark EC; Yawn BP; Galliher JM; Temte JL; Hickner J
    Fam Med; 2005 Oct; 37(9):644-9. PubMed ID: 16193428
    [TBL] [Abstract][Full Text] [Related]  

  • 89. An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease.
    Olson MR; Grewal KS; Bingaman A; Zaki R; Stewart S; Horton J; Araya V; Ortiz J
    Exp Clin Transplant; 2009 Dec; 7(4):203-13. PubMed ID: 20353368
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Current therapies for chronic hepatitis C.
    Ferguson MC
    Pharmacotherapy; 2011 Jan; 31(1):92-111. PubMed ID: 21182362
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hepatitis C infection and the patient with end-stage renal disease.
    Fabrizi F; Poordad FF; Martin P
    Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
    [TBL] [Abstract][Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.